2025-07-19 - Analysis Report
Okay, here's an analysis of Teladoc Health Inc (TDOC) based on the provided data.

**Executive Summary**

Teladoc Health Inc (TDOC) is a telehealth company offering virtual healthcare services.  TDOC has significantly underperformed the S&P 500, showing negative cumulative returns and a concerning trend in profitability and financial health.

**1. Performance vs. S&P 500 (VOO)**

*   **Cumulative Returns:**
    *   TDOC: -64.73%
    *   VOO: 97.80%
*   **Divergence:**
    *   Current Divergence: -161.0
    *   Max Divergence: 456.6
    *   Min Divergence: -161.0
    *   Relative Divergence: 0.0
*   **Analysis:** TDOC has dramatically underperformed the S&P 500. The relative divergence of 0.0 indicates it's at its lowest point relative to the index within the analyzed period.

**Alpha/Beta Analysis**

| Year       | CAGR     | MDD      | Alpha     | Beta    | Cap(B) |
| :----------- | :------- | :------- | :-------- | :------ | :------- |
| 2015-2017  | 76.0%   | 60.6%   | 50.0%   | -0.0  | 6.1    |
| 2016-2018  | 128.0%  | 59.3%   | 110.0%  | -0.0  | 8.7    |
| 2017-2019  | 176.0%  | 59.3%   | 147.0%  | 0.4   | 14.7   |
| 2018-2020  | 237.0%  | 64.0%   | 217.0%  | 0.1   | 35.1   |
| 2019-2021  | -83.0%  | 64.0%   | -132.0% | 0.1   | 16.1   |
| 2020-2022  | -295.0% | 81.3%   | -297.0% | 0.0   | 4.2    |
| 2021-2023  | -488.0% | 81.3%   | -506.0% | -0.6  | 3.8    |
| 2022-2024  | -111.0% | 81.3%   | -137.0% | -0.8  | 1.6    |
| 2023-2025  | -35.0%  | 72.9%   | -84.0%  | -0.8  | 1.4    |

*   **CAGR:** The Compound Annual Growth Rate shows a drastic decline, going from high positive values in earlier periods to significantly negative values recently. This indicates a major shift in the company's growth trajectory.
*   **MDD:** The Maximum Drawdown is consistently high, reflecting significant volatility and potential for losses.
*   **Alpha:**  The Alpha values mirror the CAGR trend, showing strong outperformance in earlier years but significant underperformance (negative alpha) more recently. This highlights TDOC's inability to generate returns independent of market movements.
*   **Beta:**  Beta fluctuates but generally remains close to zero or negative, suggesting a weak or inverse correlation with the market.
*   **Cap(B):**  Market capitalization has decreased substantially over time, indicating a loss of investor confidence and market value.

**2. Recent Price Action**

*   **Current Price:** $8.05
*   **Previous Close:** $8.04
*   **Change:** 0.12
*   **5-Day Moving Average:** 8.03
*   **20-Day Moving Average:** 8.19
*   **60-Day Moving Average:** 7.48
*   **Analysis:** The stock price is slightly up from the previous close.  The 5-day moving average is below the 20-day moving average, which is below the 60-day moving average. This suggests a short-term uptrend that may be losing momentum compared to longer-term trends.

**3. Technical Indicators & Expected Return**

*   **Market Risk Indicator (MRI):** 0.3399 (Low Risk)
*   **RSI:** 43.84 (Neutral)
*   **PPO:** -1.09 (Negative)
*   **Hybrid Signal:** cash_70%_Sell 0.3% of holdings (5 shares - Caution - MRI:0.34)
*   **Delta_Previous_Relative_Divergence:** -0.4 (Short-term decline)
*   **Expected Return:** -9641.6%
*   **Analysis:**
    *   The low MRI suggests that the broader market risk is low, but this doesn't necessarily reflect the risk specific to TDOC.
    *   The RSI is neutral, indicating neither overbought nor oversold conditions.
    *   The negative PPO suggests that the short-term moving average is below the long-term moving average, indicating a downtrend.
    *   The hybrid signal recommends a high cash position (70%) and selling a small portion of holdings, reflecting a cautious outlook.
    *   The negative change in relative divergence confirms a short-term negative trend.
    *   The extremely negative expected return implies significant concerns about TDOC's future performance.

**4. Recent News & Events**

*   **Summary:** Recent news indicates volatility, scrutiny from analysts, and significant business developments.
*   **Analysis:** These news items suggest the company is undergoing significant changes and is subject to market speculation, warranting careful monitoring.

**5. Recent Earnings Analysis**

| 날짜        | EPS    | 매출       |
| :---------- | :----- | :--------- |
| 2025-05-01 | -0.53  | 0.63 B$    |
| 2024-10-31 | -0.19  | 0.64 B$    |
| 2024-08-01 | -4.92  | 0.64 B$    |
| 2024-04-26 | -0.49  | 0.65 B$    |
| 2025-05-01 | -0.49  | 0.65 B$    |

*   **EPS:** Earnings per share (EPS) is consistently negative, indicating a lack of profitability.
*   **Revenue:** Revenue is relatively stable around $0.63-0.65 billion.
*   **Analysis:** While revenue is holding steady, the consistent losses reflected in the negative EPS are concerning.

**6. Financial Information**

**Revenue and Profitability**

| Quarter      | Revenue | Profit Margin |
| :----------- | :------ | :------------ |
| 2025-03-31 | $0.63B | 68.73%        |
| 2024-12-31 | $0.64B | 70.50%        |
| 2024-09-30 | $0.64B | 71.94%        |
| 2024-06-30 | $0.64B | 70.73%        |
| 2024-03-31 | $0.65B | 69.89%        |

**Capital and Profitability**

| Quarter      | Equity | ROE      |
| :----------- | :------ | :------- |
| 2025-03-31 | $1.43B | -6.52%  |
| 2024-12-31 | $1.49B | -3.25%  |
| 2024-09-30 | $1.51B | -2.21%  |
| 2024-06-30 | $1.50B | -55.77% |
| 2024-03-31 | $2.29B | -3.58%  |

*   **Revenue:** Revenue is relatively consistent.
*   **Profit Margin:** Profit margins are high, indicating the company's ability to control costs relative to revenue.
*   **Equity:** Equity has been decreasing, which could be a sign of financial strain.
*   **ROE:** Return on Equity (ROE) is negative, confirming a lack of profitability from shareholders' equity.
*   **Analysis:** The high profit margin is positive, but the declining equity and negative ROE raise concerns about the company's long-term financial health.

**7. Overall Analysis**

TDOC is facing significant challenges. While revenue has been relatively stable and profit margins are high, consistent losses, declining equity, and a dramatically negative expected return paint a concerning picture. The company has severely underperformed the S&P 500, and technical indicators suggest a continued downtrend. Recent news indicates volatility and analyst scrutiny. A cautious approach is warranted, and investors should carefully monitor the company's progress in addressing its profitability and financial health issues. The hybrid signal suggests significantly reducing your position to 30% and holding the remaining 70% in cash.
